April 24, 2024: 10:30 AM - 12:00 PM
Rachel Upjohn Building Auditorium & webinar
Credits: 1.5
1) Discuss the evidence for the role of neuroactive steroids in the pathophysiology of perinatal depression.
2) Summarize the clinical trial efficacy and safety data for brexanolone and zuranolone.
Lectures
Neuroactive Steroids in the Pathophysiology and Treatment of Peripartum Major Depressive Disorder: A Translational Research Journey